England's National Institute for Health and Clinical Excellence (NICE) has reversed an earlier decision to cut back on government subsidies for free treatment of wet Age-Related Macular Degeneration (ARMD). The cutbacks caused much outcry in the country. State provisions for the expensive treatment will now cover 14 injections of Lucentis ...
Buying a membership today will give you:
To continue reading this article register now.